BOSTON, March 05, 2025 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. (“PathMaker”), a clinical-stage neuromodulation company developing a breakthrough non-invasive treatment approach for amyotrophic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results